nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—TGM2—breast cancer	0.433	1	CbGaD
L-Glutamine—PPAT—Fluorouracil—breast cancer	0.174	1	CbGbCtD
L-Glutamine—TGM5—nipple—breast cancer	0.00206	0.0186	CbGeAlD
L-Glutamine—TGM4—epithelium—breast cancer	0.002	0.0181	CbGeAlD
L-Glutamine—NADSYN1—mammary gland—breast cancer	0.00173	0.0156	CbGeAlD
L-Glutamine—TGM1—nipple—breast cancer	0.00167	0.0151	CbGeAlD
L-Glutamine—QARS—Azacitidine—Gemcitabine—breast cancer	0.00159	1	CbGdCrCtD
L-Glutamine—TGM3—nipple—breast cancer	0.00156	0.0141	CbGeAlD
L-Glutamine—TGM5—skin of body—breast cancer	0.00132	0.0119	CbGeAlD
L-Glutamine—TGM4—endocrine gland—breast cancer	0.00126	0.0114	CbGeAlD
L-Glutamine—TGM5—endometrium—breast cancer	0.00125	0.0112	CbGeAlD
L-Glutamine—F13A1—mammary gland—breast cancer	0.00123	0.0111	CbGeAlD
L-Glutamine—QARS—mammary gland—breast cancer	0.00117	0.0105	CbGeAlD
L-Glutamine—CTPS1—nipple—breast cancer	0.00115	0.0104	CbGeAlD
L-Glutamine—PFAS—nipple—breast cancer	0.00113	0.0102	CbGeAlD
L-Glutamine—TGM1—skin of body—breast cancer	0.00107	0.00965	CbGeAlD
L-Glutamine—GLS—embryo—breast cancer	0.00102	0.00921	CbGeAlD
L-Glutamine—F13A1—nipple—breast cancer	0.00101	0.00916	CbGeAlD
L-Glutamine—TGM2—embryo—breast cancer	0.00101	0.00911	CbGeAlD
L-Glutamine—TGM3—skin of body—breast cancer	0.001	0.00904	CbGeAlD
L-Glutamine—QARS—nipple—breast cancer	0.000964	0.0087	CbGeAlD
L-Glutamine—GFPT2—embryo—breast cancer	0.000933	0.00842	CbGeAlD
L-Glutamine—SLC1A5—mammary gland—breast cancer	0.000923	0.00833	CbGeAlD
L-Glutamine—TGM1—adipose tissue—breast cancer	0.000908	0.0082	CbGeAlD
L-Glutamine—CAD—nipple—breast cancer	0.000889	0.00803	CbGeAlD
L-Glutamine—TGM1—female reproductive system—breast cancer	0.000835	0.00753	CbGeAlD
L-Glutamine—SLC7A8—mammary gland—breast cancer	0.000831	0.0075	CbGeAlD
L-Glutamine—PPAT—nipple—breast cancer	0.000825	0.00745	CbGeAlD
L-Glutamine—TGM2—epithelium—breast cancer	0.000823	0.00743	CbGeAlD
L-Glutamine—QARS—embryo—breast cancer	0.000796	0.00718	CbGeAlD
L-Glutamine—CCBL1—endometrium—breast cancer	0.000792	0.00715	CbGeAlD
L-Glutamine—TGM2—skin of body—breast cancer	0.000783	0.00707	CbGeAlD
L-Glutamine—NADSYN1—adipose tissue—breast cancer	0.000778	0.00703	CbGeAlD
L-Glutamine—SLC1A5—nipple—breast cancer	0.000764	0.00689	CbGeAlD
L-Glutamine—TGM1—female gonad—breast cancer	0.00076	0.00686	CbGeAlD
L-Glutamine—CAD—embryo—breast cancer	0.000734	0.00662	CbGeAlD
L-Glutamine—CCBL1—pituitary gland—breast cancer	0.000717	0.00647	CbGeAlD
L-Glutamine—NADSYN1—female reproductive system—breast cancer	0.000715	0.00646	CbGeAlD
L-Glutamine—GLS2—female reproductive system—breast cancer	0.000715	0.00646	CbGeAlD
L-Glutamine—GATB—adipose tissue—breast cancer	0.000714	0.00645	CbGeAlD
L-Glutamine—CCBL1—adipose tissue—breast cancer	0.000714	0.00645	CbGeAlD
L-Glutamine—Glutathione—GPX2—breast cancer	0.000701	0.138	CrCbGaD
L-Glutamine—GLS2—adrenal gland—breast cancer	0.000698	0.0063	CbGeAlD
L-Glutamine—NADSYN1—adrenal gland—breast cancer	0.000698	0.0063	CbGeAlD
L-Glutamine—GMPS—endometrium—breast cancer	0.000695	0.00628	CbGeAlD
L-Glutamine—CTPS1—endometrium—breast cancer	0.000695	0.00628	CbGeAlD
L-Glutamine—GFPT2—endometrium—breast cancer	0.000683	0.00616	CbGeAlD
L-Glutamine—PFAS—endometrium—breast cancer	0.000683	0.00616	CbGeAlD
L-Glutamine—TGM2—uterus—breast cancer	0.00068	0.00614	CbGeAlD
L-Glutamine—GLS—adipose tissue—breast cancer	0.000673	0.00607	CbGeAlD
L-Glutamine—TGM3—endocrine gland—breast cancer	0.000662	0.00598	CbGeAlD
L-Glutamine—GATB—female reproductive system—breast cancer	0.000656	0.00593	CbGeAlD
L-Glutamine—ASNS—nipple—breast cancer	0.000655	0.00591	CbGeAlD
L-Glutamine—NADSYN1—female gonad—breast cancer	0.000651	0.00588	CbGeAlD
L-Glutamine—GLS2—female gonad—breast cancer	0.000651	0.00588	CbGeAlD
L-Glutamine—GLUL—mammary gland—breast cancer	0.000647	0.00584	CbGeAlD
L-Glutamine—CTPS1—uterus—breast cancer	0.000641	0.00578	CbGeAlD
L-Glutamine—CCBL1—adrenal gland—breast cancer	0.000641	0.00578	CbGeAlD
L-Glutamine—GATB—adrenal gland—breast cancer	0.000641	0.00578	CbGeAlD
L-Glutamine—CTPS1—pituitary gland—breast cancer	0.000629	0.00568	CbGeAlD
L-Glutamine—GMPS—pituitary gland—breast cancer	0.000629	0.00568	CbGeAlD
L-Glutamine—GFPT2—uterus—breast cancer	0.000629	0.00568	CbGeAlD
L-Glutamine—CTPS1—adipose tissue—breast cancer	0.000627	0.00566	CbGeAlD
L-Glutamine—GMPS—adipose tissue—breast cancer	0.000627	0.00566	CbGeAlD
L-Glutamine—GLS—female reproductive system—breast cancer	0.000618	0.00558	CbGeAlD
L-Glutamine—PFAS—pituitary gland—breast cancer	0.000618	0.00558	CbGeAlD
L-Glutamine—GFPT2—pituitary gland—breast cancer	0.000618	0.00558	CbGeAlD
L-Glutamine—QARS—skin of body—breast cancer	0.000618	0.00557	CbGeAlD
L-Glutamine—PFAS—adipose tissue—breast cancer	0.000615	0.00555	CbGeAlD
L-Glutamine—GFPT2—adipose tissue—breast cancer	0.000615	0.00555	CbGeAlD
L-Glutamine—F13A1—endometrium—breast cancer	0.000613	0.00553	CbGeAlD
L-Glutamine—TGM2—female reproductive system—breast cancer	0.000612	0.00552	CbGeAlD
L-Glutamine—GLS2—endocrine gland—breast cancer	0.000605	0.00546	CbGeAlD
L-Glutamine—NADSYN1—endocrine gland—breast cancer	0.000605	0.00546	CbGeAlD
L-Glutamine—GLS—adrenal gland—breast cancer	0.000603	0.00545	CbGeAlD
L-Glutamine—GATB—female gonad—breast cancer	0.000597	0.00539	CbGeAlD
L-Glutamine—CCBL1—female gonad—breast cancer	0.000597	0.00539	CbGeAlD
L-Glutamine—Glutathione—GPX4—breast cancer	0.000596	0.117	CrCbGaD
L-Glutamine—GLS—bone marrow—breast cancer	0.000584	0.00527	CbGeAlD
L-Glutamine—QARS—endometrium—breast cancer	0.000582	0.00526	CbGeAlD
L-Glutamine—CTPS1—female reproductive system—breast cancer	0.000576	0.0052	CbGeAlD
L-Glutamine—GMPS—female reproductive system—breast cancer	0.000576	0.0052	CbGeAlD
L-Glutamine—GFPT2—female reproductive system—breast cancer	0.000566	0.0051	CbGeAlD
L-Glutamine—PFAS—female reproductive system—breast cancer	0.000566	0.0051	CbGeAlD
L-Glutamine—F13A1—uterus—breast cancer	0.000565	0.0051	CbGeAlD
L-Glutamine—GLS—female gonad—breast cancer	0.000563	0.00508	CbGeAlD
L-Glutamine—CTPS1—adrenal gland—breast cancer	0.000562	0.00507	CbGeAlD
L-Glutamine—GMPS—adrenal gland—breast cancer	0.000562	0.00507	CbGeAlD
L-Glutamine—TGM2—female gonad—breast cancer	0.000557	0.00502	CbGeAlD
L-Glutamine—F13A1—pituitary gland—breast cancer	0.000554	0.005	CbGeAlD
L-Glutamine—F13A1—adipose tissue—breast cancer	0.000552	0.00498	CbGeAlD
L-Glutamine—PFAS—adrenal gland—breast cancer	0.000552	0.00498	CbGeAlD
L-Glutamine—GFPT2—adrenal gland—breast cancer	0.000552	0.00498	CbGeAlD
L-Glutamine—GMPS—bone marrow—breast cancer	0.000544	0.00491	CbGeAlD
L-Glutamine—CTPS1—bone marrow—breast cancer	0.000544	0.00491	CbGeAlD
L-Glutamine—CAD—endometrium—breast cancer	0.000537	0.00485	CbGeAlD
L-Glutamine—QARS—uterus—breast cancer	0.000537	0.00484	CbGeAlD
L-Glutamine—PFAS—bone marrow—breast cancer	0.000534	0.00482	CbGeAlD
L-Glutamine—Glutathione—GSTA3—breast cancer	0.000531	0.104	CrCbGaD
L-Glutamine—QARS—pituitary gland—breast cancer	0.000527	0.00476	CbGeAlD
L-Glutamine—QARS—adipose tissue—breast cancer	0.000525	0.00474	CbGeAlD
L-Glutamine—GMPS—female gonad—breast cancer	0.000524	0.00473	CbGeAlD
L-Glutamine—CTPS1—female gonad—breast cancer	0.000524	0.00473	CbGeAlD
L-Glutamine—GLS—endocrine gland—breast cancer	0.000523	0.00472	CbGeAlD
L-Glutamine—TGM2—endocrine gland—breast cancer	0.000518	0.00467	CbGeAlD
L-Glutamine—GFPT2—female gonad—breast cancer	0.000515	0.00464	CbGeAlD
L-Glutamine—PFAS—female gonad—breast cancer	0.000515	0.00464	CbGeAlD
L-Glutamine—SLC1A5—epithelium—breast cancer	0.000514	0.00464	CbGeAlD
L-Glutamine—F13A1—female reproductive system—breast cancer	0.000507	0.00458	CbGeAlD
L-Glutamine—PPAT—endometrium—breast cancer	0.000498	0.0045	CbGeAlD
L-Glutamine—F13A1—adrenal gland—breast cancer	0.000495	0.00447	CbGeAlD
L-Glutamine—CAD—uterus—breast cancer	0.000495	0.00447	CbGeAlD
L-Glutamine—SLC1A5—skin of body—breast cancer	0.000489	0.00441	CbGeAlD
L-Glutamine—TGM1—lymph node—breast cancer	0.000488	0.00441	CbGeAlD
L-Glutamine—GMPS—endocrine gland—breast cancer	0.000487	0.0044	CbGeAlD
L-Glutamine—CTPS1—endocrine gland—breast cancer	0.000487	0.0044	CbGeAlD
L-Glutamine—CAD—pituitary gland—breast cancer	0.000486	0.00439	CbGeAlD
L-Glutamine—Glutathione—GSTA4—breast cancer	0.000486	0.0953	CrCbGaD
L-Glutamine—CAD—adipose tissue—breast cancer	0.000484	0.00437	CbGeAlD
L-Glutamine—QARS—female reproductive system—breast cancer	0.000482	0.00435	CbGeAlD
L-Glutamine—F13A1—bone marrow—breast cancer	0.000479	0.00432	CbGeAlD
L-Glutamine—PFAS—endocrine gland—breast cancer	0.000479	0.00432	CbGeAlD
L-Glutamine—GFPT2—endocrine gland—breast cancer	0.000479	0.00432	CbGeAlD
L-Glutamine—QARS—adrenal gland—breast cancer	0.000471	0.00425	CbGeAlD
L-Glutamine—F13A1—female gonad—breast cancer	0.000462	0.00417	CbGeAlD
L-Glutamine—SLC1A5—endometrium—breast cancer	0.000461	0.00416	CbGeAlD
L-Glutamine—QARS—bone marrow—breast cancer	0.000455	0.00411	CbGeAlD
L-Glutamine—PPAT—pituitary gland—breast cancer	0.000451	0.00407	CbGeAlD
L-Glutamine—PPAT—adipose tissue—breast cancer	0.000449	0.00405	CbGeAlD
L-Glutamine—CAD—female reproductive system—breast cancer	0.000445	0.00402	CbGeAlD
L-Glutamine—GLUL—embryo—breast cancer	0.000442	0.00399	CbGeAlD
L-Glutamine—SLC7A8—skin of body—breast cancer	0.00044	0.00398	CbGeAlD
L-Glutamine—QARS—female gonad—breast cancer	0.000439	0.00396	CbGeAlD
L-Glutamine—CAD—adrenal gland—breast cancer	0.000434	0.00392	CbGeAlD
L-Glutamine—F13A1—endocrine gland—breast cancer	0.000429	0.00388	CbGeAlD
L-Glutamine—SLC1A5—uterus—breast cancer	0.000425	0.00384	CbGeAlD
L-Glutamine—CAD—bone marrow—breast cancer	0.00042	0.00379	CbGeAlD
L-Glutamine—NADSYN1—lymph node—breast cancer	0.000419	0.00378	CbGeAlD
L-Glutamine—GLS2—lymph node—breast cancer	0.000419	0.00378	CbGeAlD
L-Glutamine—SLC1A5—pituitary gland—breast cancer	0.000417	0.00377	CbGeAlD
L-Glutamine—SLC1A5—adipose tissue—breast cancer	0.000416	0.00375	CbGeAlD
L-Glutamine—PPAT—female reproductive system—breast cancer	0.000413	0.00372	CbGeAlD
L-Glutamine—QARS—endocrine gland—breast cancer	0.000408	0.00368	CbGeAlD
L-Glutamine—SLC16A10—nipple—breast cancer	0.000408	0.00368	CbGeAlD
L-Glutamine—CAD—female gonad—breast cancer	0.000405	0.00365	CbGeAlD
L-Glutamine—PPAT—adrenal gland—breast cancer	0.000403	0.00363	CbGeAlD
L-Glutamine—ASNS—endometrium—breast cancer	0.000396	0.00357	CbGeAlD
L-Glutamine—PPAT—bone marrow—breast cancer	0.00039	0.00352	CbGeAlD
L-Glutamine—CCBL1—lymph node—breast cancer	0.000384	0.00347	CbGeAlD
L-Glutamine—GATB—lymph node—breast cancer	0.000384	0.00347	CbGeAlD
L-Glutamine—SLC1A5—female reproductive system—breast cancer	0.000382	0.00345	CbGeAlD
L-Glutamine—CAD—endocrine gland—breast cancer	0.000376	0.0034	CbGeAlD
L-Glutamine—SLC7A8—pituitary gland—breast cancer	0.000376	0.00339	CbGeAlD
L-Glutamine—PPAT—female gonad—breast cancer	0.000375	0.00339	CbGeAlD
L-Glutamine—SLC7A8—adipose tissue—breast cancer	0.000374	0.00338	CbGeAlD
L-Glutamine—SLC1A5—adrenal gland—breast cancer	0.000373	0.00336	CbGeAlD
L-Glutamine—ASNS—uterus—breast cancer	0.000365	0.00329	CbGeAlD
L-Glutamine—GLS—lymph node—breast cancer	0.000362	0.00326	CbGeAlD
L-Glutamine—SLC1A5—bone marrow—breast cancer	0.000361	0.00326	CbGeAlD
L-Glutamine—GLUL—epithelium—breast cancer	0.00036	0.00325	CbGeAlD
L-Glutamine—ASNS—pituitary gland—breast cancer	0.000358	0.00323	CbGeAlD
L-Glutamine—ASNS—adipose tissue—breast cancer	0.000357	0.00322	CbGeAlD
L-Glutamine—PPAT—endocrine gland—breast cancer	0.000349	0.00315	CbGeAlD
L-Glutamine—SLC1A5—female gonad—breast cancer	0.000348	0.00314	CbGeAlD
L-Glutamine—SLC7A8—female reproductive system—breast cancer	0.000344	0.0031	CbGeAlD
L-Glutamine—GLUL—skin of body—breast cancer	0.000343	0.00309	CbGeAlD
L-Glutamine—CTPS1—lymph node—breast cancer	0.000337	0.00304	CbGeAlD
L-Glutamine—GMPS—lymph node—breast cancer	0.000337	0.00304	CbGeAlD
L-Glutamine—SLC7A8—adrenal gland—breast cancer	0.000336	0.00303	CbGeAlD
L-Glutamine—Glutathione—GPX1—breast cancer	0.000331	0.0651	CrCbGaD
L-Glutamine—GFPT2—lymph node—breast cancer	0.000331	0.00299	CbGeAlD
L-Glutamine—PFAS—lymph node—breast cancer	0.000331	0.00299	CbGeAlD
L-Glutamine—SLC1A5—endocrine gland—breast cancer	0.000323	0.00292	CbGeAlD
L-Glutamine—GLUL—endometrium—breast cancer	0.000323	0.00292	CbGeAlD
L-Glutamine—ASNS—adrenal gland—breast cancer	0.00032	0.00289	CbGeAlD
L-Glutamine—Glutathione—GSTA1—breast cancer	0.000313	0.0614	CrCbGaD
L-Glutamine—SLC7A8—female gonad—breast cancer	0.000313	0.00282	CbGeAlD
L-Glutamine—ASNS—bone marrow—breast cancer	0.000309	0.00279	CbGeAlD
L-Glutamine—L-Methionine—MTR—breast cancer	0.000302	0.0593	CrCbGaD
L-Glutamine—ASNS—female gonad—breast cancer	0.000298	0.00269	CbGeAlD
L-Glutamine—GLUL—uterus—breast cancer	0.000298	0.00269	CbGeAlD
L-Glutamine—F13A1—lymph node—breast cancer	0.000297	0.00268	CbGeAlD
L-Glutamine—GLUL—pituitary gland—breast cancer	0.000292	0.00264	CbGeAlD
L-Glutamine—GLUL—adipose tissue—breast cancer	0.000291	0.00263	CbGeAlD
L-Glutamine—SLC7A8—endocrine gland—breast cancer	0.000291	0.00263	CbGeAlD
L-Glutamine—QARS—lymph node—breast cancer	0.000282	0.00255	CbGeAlD
L-Glutamine—SLC16A10—epithelium—breast cancer	0.000275	0.00248	CbGeAlD
L-Glutamine—Glutathione—HPGDS—breast cancer	0.000274	0.0537	CrCbGaD
L-Glutamine—GLUL—female reproductive system—breast cancer	0.000268	0.00242	CbGeAlD
L-Glutamine—GLUL—adrenal gland—breast cancer	0.000261	0.00236	CbGeAlD
L-Glutamine—CAD—lymph node—breast cancer	0.00026	0.00235	CbGeAlD
L-Glutamine—GLUL—bone marrow—breast cancer	0.000253	0.00228	CbGeAlD
L-Glutamine—Glutathione—GSTA2—breast cancer	0.000244	0.0479	CrCbGaD
L-Glutamine—GLUL—female gonad—breast cancer	0.000244	0.0022	CbGeAlD
L-Glutamine—PPAT—lymph node—breast cancer	0.000241	0.00218	CbGeAlD
L-Glutamine—GLUL—endocrine gland—breast cancer	0.000227	0.00204	CbGeAlD
L-Glutamine—SLC1A5—lymph node—breast cancer	0.000223	0.00202	CbGeAlD
L-Glutamine—SLC16A10—adipose tissue—breast cancer	0.000222	0.002	CbGeAlD
L-Glutamine—SLC16A10—female reproductive system—breast cancer	0.000204	0.00184	CbGeAlD
L-Glutamine—SLC7A8—lymph node—breast cancer	0.000201	0.00182	CbGeAlD
L-Glutamine—ASNS—lymph node—breast cancer	0.000192	0.00173	CbGeAlD
L-Glutamine—L-Arginine—NOS3—breast cancer	0.000178	0.035	CrCbGaD
L-Glutamine—SLC16A10—endocrine gland—breast cancer	0.000173	0.00156	CbGeAlD
L-Glutamine—L-Arginine—NOS2—breast cancer	0.000172	0.0338	CrCbGaD
L-Glutamine—GLUL—lymph node—breast cancer	0.000157	0.00141	CbGeAlD
L-Glutamine—Glutathione—GSTT1—breast cancer	0.000156	0.0307	CrCbGaD
L-Glutamine—Glutathione—ABCC1—breast cancer	0.000152	0.0297	CrCbGaD
L-Glutamine—L-Citrulline—NOS3—breast cancer	0.000151	0.0297	CrCbGaD
L-Glutamine—L-Citrulline—NOS2—breast cancer	0.000146	0.0287	CrCbGaD
L-Glutamine—Glutathione—GSTM1—breast cancer	0.000134	0.0262	CrCbGaD
L-Glutamine—Glutathione—GSTP1—breast cancer	0.000124	0.0243	CrCbGaD
L-Glutamine—SLC16A10—lymph node—breast cancer	0.000119	0.00108	CbGeAlD
L-Glutamine—L-Methionine—MTHFR—breast cancer	0.000103	0.0203	CrCbGaD
L-Glutamine—Feeling abnormal—Irinotecan—breast cancer	7.87e-05	0.000588	CcSEcCtD
L-Glutamine—Feeling abnormal—Mitoxantrone—breast cancer	7.87e-05	0.000588	CcSEcCtD
L-Glutamine—Malnutrition—Capecitabine—breast cancer	7.83e-05	0.000586	CcSEcCtD
L-Glutamine—Back pain—Docetaxel—breast cancer	7.82e-05	0.000585	CcSEcCtD
L-Glutamine—Pruritus—Thiotepa—breast cancer	7.82e-05	0.000585	CcSEcCtD
L-Glutamine—Pain—Fluorouracil—breast cancer	7.82e-05	0.000585	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Irinotecan—breast cancer	7.81e-05	0.000584	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Mitoxantrone—breast cancer	7.81e-05	0.000584	CcSEcCtD
L-Glutamine—Dehydration—Doxorubicin—breast cancer	7.79e-05	0.000583	CcSEcCtD
L-Glutamine—Oedema—Paclitaxel—breast cancer	7.79e-05	0.000582	CcSEcCtD
L-Glutamine—Infection—Paclitaxel—breast cancer	7.74e-05	0.000579	CcSEcCtD
L-Glutamine—Flatulence—Capecitabine—breast cancer	7.71e-05	0.000577	CcSEcCtD
L-Glutamine—Nausea—Goserelin—breast cancer	7.68e-05	0.000574	CcSEcCtD
L-Glutamine—Pancreatitis—Epirubicin—breast cancer	7.67e-05	0.000574	CcSEcCtD
L-Glutamine—Feeling abnormal—Gemcitabine—breast cancer	7.66e-05	0.000573	CcSEcCtD
L-Glutamine—Dizziness—Vinorelbine—breast cancer	7.66e-05	0.000573	CcSEcCtD
L-Glutamine—Back pain—Capecitabine—breast cancer	7.57e-05	0.000566	CcSEcCtD
L-Glutamine—Abdominal pain—Irinotecan—breast cancer	7.55e-05	0.000564	CcSEcCtD
L-Glutamine—Abdominal pain—Mitoxantrone—breast cancer	7.55e-05	0.000564	CcSEcCtD
L-Glutamine—Body temperature increased—Mitoxantrone—breast cancer	7.55e-05	0.000564	CcSEcCtD
L-Glutamine—Body temperature increased—Irinotecan—breast cancer	7.55e-05	0.000564	CcSEcCtD
L-Glutamine—Feeling abnormal—Fluorouracil—breast cancer	7.54e-05	0.000564	CcSEcCtD
L-Glutamine—Hyperhidrosis—Paclitaxel—breast cancer	7.53e-05	0.000563	CcSEcCtD
L-Glutamine—Depression—Methotrexate—breast cancer	7.44e-05	0.000556	CcSEcCtD
L-Glutamine—Vomiting—Vinorelbine—breast cancer	7.36e-05	0.00055	CcSEcCtD
L-Glutamine—Body temperature increased—Gemcitabine—breast cancer	7.35e-05	0.00055	CcSEcCtD
L-Glutamine—Dizziness—Thiotepa—breast cancer	7.31e-05	0.000547	CcSEcCtD
L-Glutamine—Rash—Vinorelbine—breast cancer	7.3e-05	0.000546	CcSEcCtD
L-Glutamine—Dermatitis—Vinorelbine—breast cancer	7.29e-05	0.000545	CcSEcCtD
L-Glutamine—Abdominal distension—Doxorubicin—breast cancer	7.29e-05	0.000545	CcSEcCtD
L-Glutamine—Ill-defined disorder—Capecitabine—breast cancer	7.26e-05	0.000543	CcSEcCtD
L-Glutamine—Headache—Vinorelbine—breast cancer	7.25e-05	0.000542	CcSEcCtD
L-Glutamine—Body temperature increased—Fluorouracil—breast cancer	7.23e-05	0.000541	CcSEcCtD
L-Glutamine—Pancreatitis—Doxorubicin—breast cancer	7.1e-05	0.000531	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Paclitaxel—breast cancer	7.09e-05	0.000531	CcSEcCtD
L-Glutamine—Malaise—Capecitabine—breast cancer	7.06e-05	0.000528	CcSEcCtD
L-Glutamine—Insomnia—Paclitaxel—breast cancer	7.04e-05	0.000527	CcSEcCtD
L-Glutamine—Hypersensitivity—Irinotecan—breast cancer	7.03e-05	0.000526	CcSEcCtD
L-Glutamine—Hypersensitivity—Mitoxantrone—breast cancer	7.03e-05	0.000526	CcSEcCtD
L-Glutamine—Vomiting—Thiotepa—breast cancer	7.03e-05	0.000526	CcSEcCtD
L-Glutamine—Rash—Thiotepa—breast cancer	6.97e-05	0.000521	CcSEcCtD
L-Glutamine—Dermatitis—Thiotepa—breast cancer	6.96e-05	0.000521	CcSEcCtD
L-Glutamine—Headache—Thiotepa—breast cancer	6.93e-05	0.000518	CcSEcCtD
L-Glutamine—Myalgia—Docetaxel—breast cancer	6.88e-05	0.000515	CcSEcCtD
L-Glutamine—Chest pain—Docetaxel—breast cancer	6.88e-05	0.000515	CcSEcCtD
L-Glutamine—Arthralgia—Docetaxel—breast cancer	6.88e-05	0.000515	CcSEcCtD
L-Glutamine—Nausea—Vinorelbine—breast cancer	6.88e-05	0.000514	CcSEcCtD
L-Glutamine—Asthenia—Mitoxantrone—breast cancer	6.85e-05	0.000512	CcSEcCtD
L-Glutamine—Asthenia—Irinotecan—breast cancer	6.85e-05	0.000512	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Epirubicin—breast cancer	6.84e-05	0.000512	CcSEcCtD
L-Glutamine—Hypersensitivity—Fluorouracil—breast cancer	6.74e-05	0.000504	CcSEcCtD
L-Glutamine—Dry mouth—Docetaxel—breast cancer	6.73e-05	0.000504	CcSEcCtD
L-Glutamine—Fatigue—Paclitaxel—breast cancer	6.71e-05	0.000502	CcSEcCtD
L-Glutamine—Asthenia—Gemcitabine—breast cancer	6.67e-05	0.000499	CcSEcCtD
L-Glutamine—Chest pain—Capecitabine—breast cancer	6.67e-05	0.000499	CcSEcCtD
L-Glutamine—Arthralgia—Capecitabine—breast cancer	6.67e-05	0.000499	CcSEcCtD
L-Glutamine—Myalgia—Capecitabine—breast cancer	6.67e-05	0.000499	CcSEcCtD
L-Glutamine—Constipation—Paclitaxel—breast cancer	6.66e-05	0.000498	CcSEcCtD
L-Glutamine—Pain—Paclitaxel—breast cancer	6.66e-05	0.000498	CcSEcCtD
L-Glutamine—Pharyngitis—Methotrexate—breast cancer	6.65e-05	0.000497	CcSEcCtD
L-Glutamine—Urinary tract disorder—Methotrexate—breast cancer	6.61e-05	0.000495	CcSEcCtD
L-Glutamine—Oedema—Docetaxel—breast cancer	6.6e-05	0.000494	CcSEcCtD
L-Glutamine—Discomfort—Capecitabine—breast cancer	6.59e-05	0.000493	CcSEcCtD
L-Glutamine—Pruritus—Gemcitabine—breast cancer	6.58e-05	0.000492	CcSEcCtD
L-Glutamine—Nausea—Thiotepa—breast cancer	6.57e-05	0.000491	CcSEcCtD
L-Glutamine—Urethral disorder—Methotrexate—breast cancer	6.56e-05	0.000491	CcSEcCtD
L-Glutamine—Infection—Docetaxel—breast cancer	6.56e-05	0.00049	CcSEcCtD
L-Glutamine—Dry mouth—Capecitabine—breast cancer	6.52e-05	0.000488	CcSEcCtD
L-Glutamine—Pruritus—Fluorouracil—breast cancer	6.47e-05	0.000484	CcSEcCtD
L-Glutamine—Feeling abnormal—Paclitaxel—breast cancer	6.42e-05	0.00048	CcSEcCtD
L-Glutamine—Oedema—Capecitabine—breast cancer	6.39e-05	0.000478	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Paclitaxel—breast cancer	6.37e-05	0.000476	CcSEcCtD
L-Glutamine—Infection—Capecitabine—breast cancer	6.35e-05	0.000475	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Doxorubicin—breast cancer	6.33e-05	0.000473	CcSEcCtD
L-Glutamine—Dizziness—Irinotecan—breast cancer	6.31e-05	0.000472	CcSEcCtD
L-Glutamine—Rhinitis—Epirubicin—breast cancer	6.28e-05	0.00047	CcSEcCtD
L-Glutamine—Pharyngitis—Epirubicin—breast cancer	6.22e-05	0.000465	CcSEcCtD
L-Glutamine—Urinary tract disorder—Epirubicin—breast cancer	6.19e-05	0.000463	CcSEcCtD
L-Glutamine—Hyperhidrosis—Capecitabine—breast cancer	6.18e-05	0.000462	CcSEcCtD
L-Glutamine—Abdominal pain—Paclitaxel—breast cancer	6.16e-05	0.00046	CcSEcCtD
L-Glutamine—Body temperature increased—Paclitaxel—breast cancer	6.16e-05	0.00046	CcSEcCtD
L-Glutamine—Urethral disorder—Epirubicin—breast cancer	6.14e-05	0.000459	CcSEcCtD
L-Glutamine—Angiopathy—Methotrexate—breast cancer	6.07e-05	0.000454	CcSEcCtD
L-Glutamine—Vomiting—Mitoxantrone—breast cancer	6.07e-05	0.000454	CcSEcCtD
L-Glutamine—Vomiting—Irinotecan—breast cancer	6.07e-05	0.000454	CcSEcCtD
L-Glutamine—Dizziness—Fluorouracil—breast cancer	6.05e-05	0.000452	CcSEcCtD
L-Glutamine—Rash—Irinotecan—breast cancer	6.02e-05	0.00045	CcSEcCtD
L-Glutamine—Rash—Mitoxantrone—breast cancer	6.02e-05	0.00045	CcSEcCtD
L-Glutamine—Dermatitis—Mitoxantrone—breast cancer	6.01e-05	0.00045	CcSEcCtD
L-Glutamine—Dermatitis—Irinotecan—breast cancer	6.01e-05	0.00045	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Docetaxel—breast cancer	6.01e-05	0.00045	CcSEcCtD
L-Glutamine—Chills—Methotrexate—breast cancer	6.01e-05	0.000449	CcSEcCtD
L-Glutamine—Headache—Mitoxantrone—breast cancer	5.98e-05	0.000447	CcSEcCtD
L-Glutamine—Headache—Irinotecan—breast cancer	5.98e-05	0.000447	CcSEcCtD
L-Glutamine—Insomnia—Docetaxel—breast cancer	5.97e-05	0.000446	CcSEcCtD
L-Glutamine—Vomiting—Gemcitabine—breast cancer	5.91e-05	0.000442	CcSEcCtD
L-Glutamine—Mental disorder—Methotrexate—breast cancer	5.87e-05	0.000439	CcSEcCtD
L-Glutamine—Rash—Gemcitabine—breast cancer	5.86e-05	0.000439	CcSEcCtD
L-Glutamine—Dermatitis—Gemcitabine—breast cancer	5.86e-05	0.000438	CcSEcCtD
L-Glutamine—Malnutrition—Methotrexate—breast cancer	5.83e-05	0.000436	CcSEcCtD
L-Glutamine—Headache—Gemcitabine—breast cancer	5.83e-05	0.000436	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Capecitabine—breast cancer	5.82e-05	0.000435	CcSEcCtD
L-Glutamine—Vomiting—Fluorouracil—breast cancer	5.81e-05	0.000435	CcSEcCtD
L-Glutamine—Rhinitis—Doxorubicin—breast cancer	5.81e-05	0.000435	CcSEcCtD
L-Glutamine—Insomnia—Capecitabine—breast cancer	5.78e-05	0.000432	CcSEcCtD
L-Glutamine—Rash—Fluorouracil—breast cancer	5.77e-05	0.000431	CcSEcCtD
L-Glutamine—Dermatitis—Fluorouracil—breast cancer	5.76e-05	0.000431	CcSEcCtD
L-Glutamine—Pharyngitis—Doxorubicin—breast cancer	5.75e-05	0.00043	CcSEcCtD
L-Glutamine—Hypersensitivity—Paclitaxel—breast cancer	5.74e-05	0.000429	CcSEcCtD
L-Glutamine—Headache—Fluorouracil—breast cancer	5.73e-05	0.000428	CcSEcCtD
L-Glutamine—Urinary tract disorder—Doxorubicin—breast cancer	5.73e-05	0.000428	CcSEcCtD
L-Glutamine—Fatigue—Docetaxel—breast cancer	5.69e-05	0.000426	CcSEcCtD
L-Glutamine—Angiopathy—Epirubicin—breast cancer	5.68e-05	0.000425	CcSEcCtD
L-Glutamine—Urethral disorder—Doxorubicin—breast cancer	5.68e-05	0.000425	CcSEcCtD
L-Glutamine—Nausea—Mitoxantrone—breast cancer	5.67e-05	0.000424	CcSEcCtD
L-Glutamine—Nausea—Irinotecan—breast cancer	5.67e-05	0.000424	CcSEcCtD
L-Glutamine—Pain—Docetaxel—breast cancer	5.64e-05	0.000422	CcSEcCtD
L-Glutamine—Constipation—Docetaxel—breast cancer	5.64e-05	0.000422	CcSEcCtD
L-Glutamine—Back pain—Methotrexate—breast cancer	5.64e-05	0.000422	CcSEcCtD
L-Glutamine—Chills—Epirubicin—breast cancer	5.62e-05	0.00042	CcSEcCtD
L-Glutamine—Asthenia—Paclitaxel—breast cancer	5.59e-05	0.000418	CcSEcCtD
L-Glutamine—Nausea—Gemcitabine—breast cancer	5.52e-05	0.000413	CcSEcCtD
L-Glutamine—Fatigue—Capecitabine—breast cancer	5.51e-05	0.000412	CcSEcCtD
L-Glutamine—Pruritus—Paclitaxel—breast cancer	5.51e-05	0.000412	CcSEcCtD
L-Glutamine—Mental disorder—Epirubicin—breast cancer	5.49e-05	0.000411	CcSEcCtD
L-Glutamine—Pain—Capecitabine—breast cancer	5.46e-05	0.000409	CcSEcCtD
L-Glutamine—Constipation—Capecitabine—breast cancer	5.46e-05	0.000409	CcSEcCtD
L-Glutamine—Malnutrition—Epirubicin—breast cancer	5.45e-05	0.000408	CcSEcCtD
L-Glutamine—Feeling abnormal—Docetaxel—breast cancer	5.44e-05	0.000407	CcSEcCtD
L-Glutamine—Nausea—Fluorouracil—breast cancer	5.43e-05	0.000406	CcSEcCtD
L-Glutamine—Ill-defined disorder—Methotrexate—breast cancer	5.41e-05	0.000404	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Docetaxel—breast cancer	5.4e-05	0.000404	CcSEcCtD
L-Glutamine—Flatulence—Epirubicin—breast cancer	5.37e-05	0.000402	CcSEcCtD
L-Glutamine—Back pain—Epirubicin—breast cancer	5.28e-05	0.000395	CcSEcCtD
L-Glutamine—Feeling abnormal—Capecitabine—breast cancer	5.27e-05	0.000394	CcSEcCtD
L-Glutamine—Angiopathy—Doxorubicin—breast cancer	5.26e-05	0.000393	CcSEcCtD
L-Glutamine—Malaise—Methotrexate—breast cancer	5.26e-05	0.000393	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Capecitabine—breast cancer	5.23e-05	0.000391	CcSEcCtD
L-Glutamine—Abdominal pain—Docetaxel—breast cancer	5.22e-05	0.00039	CcSEcCtD
L-Glutamine—Body temperature increased—Docetaxel—breast cancer	5.22e-05	0.00039	CcSEcCtD
L-Glutamine—Chills—Doxorubicin—breast cancer	5.2e-05	0.000389	CcSEcCtD
L-Glutamine—Dizziness—Paclitaxel—breast cancer	5.15e-05	0.000385	CcSEcCtD
L-Glutamine—Mental disorder—Doxorubicin—breast cancer	5.08e-05	0.00038	CcSEcCtD
L-Glutamine—Ill-defined disorder—Epirubicin—breast cancer	5.06e-05	0.000378	CcSEcCtD
L-Glutamine—Body temperature increased—Capecitabine—breast cancer	5.05e-05	0.000378	CcSEcCtD
L-Glutamine—Abdominal pain—Capecitabine—breast cancer	5.05e-05	0.000378	CcSEcCtD
L-Glutamine—Malnutrition—Doxorubicin—breast cancer	5.05e-05	0.000377	CcSEcCtD
L-Glutamine—Flatulence—Doxorubicin—breast cancer	4.97e-05	0.000372	CcSEcCtD
L-Glutamine—Chest pain—Methotrexate—breast cancer	4.96e-05	0.000371	CcSEcCtD
L-Glutamine—Arthralgia—Methotrexate—breast cancer	4.96e-05	0.000371	CcSEcCtD
L-Glutamine—Myalgia—Methotrexate—breast cancer	4.96e-05	0.000371	CcSEcCtD
L-Glutamine—Vomiting—Paclitaxel—breast cancer	4.95e-05	0.00037	CcSEcCtD
L-Glutamine—Malaise—Epirubicin—breast cancer	4.92e-05	0.000368	CcSEcCtD
L-Glutamine—Rash—Paclitaxel—breast cancer	4.91e-05	0.000367	CcSEcCtD
L-Glutamine—Dermatitis—Paclitaxel—breast cancer	4.9e-05	0.000367	CcSEcCtD
L-Glutamine—Discomfort—Methotrexate—breast cancer	4.9e-05	0.000367	CcSEcCtD
L-Glutamine—Back pain—Doxorubicin—breast cancer	4.88e-05	0.000365	CcSEcCtD
L-Glutamine—Headache—Paclitaxel—breast cancer	4.88e-05	0.000365	CcSEcCtD
L-Glutamine—Hypersensitivity—Docetaxel—breast cancer	4.86e-05	0.000364	CcSEcCtD
L-Glutamine—Asthenia—Docetaxel—breast cancer	4.74e-05	0.000354	CcSEcCtD
L-Glutamine—Infection—Methotrexate—breast cancer	4.73e-05	0.000353	CcSEcCtD
L-Glutamine—Hypersensitivity—Capecitabine—breast cancer	4.71e-05	0.000352	CcSEcCtD
L-Glutamine—Ill-defined disorder—Doxorubicin—breast cancer	4.68e-05	0.00035	CcSEcCtD
L-Glutamine—Pruritus—Docetaxel—breast cancer	4.67e-05	0.000349	CcSEcCtD
L-Glutamine—Myalgia—Epirubicin—breast cancer	4.64e-05	0.000347	CcSEcCtD
L-Glutamine—Chest pain—Epirubicin—breast cancer	4.64e-05	0.000347	CcSEcCtD
L-Glutamine—Arthralgia—Epirubicin—breast cancer	4.64e-05	0.000347	CcSEcCtD
L-Glutamine—Nausea—Paclitaxel—breast cancer	4.62e-05	0.000346	CcSEcCtD
L-Glutamine—Hyperhidrosis—Methotrexate—breast cancer	4.6e-05	0.000344	CcSEcCtD
L-Glutamine—Discomfort—Epirubicin—breast cancer	4.59e-05	0.000343	CcSEcCtD
L-Glutamine—Asthenia—Capecitabine—breast cancer	4.58e-05	0.000343	CcSEcCtD
L-Glutamine—Malaise—Doxorubicin—breast cancer	4.55e-05	0.00034	CcSEcCtD
L-Glutamine—Dry mouth—Epirubicin—breast cancer	4.54e-05	0.00034	CcSEcCtD
L-Glutamine—Pruritus—Capecitabine—breast cancer	4.52e-05	0.000338	CcSEcCtD
L-Glutamine—Oedema—Epirubicin—breast cancer	4.45e-05	0.000333	CcSEcCtD
L-Glutamine—Infection—Epirubicin—breast cancer	4.42e-05	0.000331	CcSEcCtD
L-Glutamine—Dizziness—Docetaxel—breast cancer	4.36e-05	0.000326	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Methotrexate—breast cancer	4.33e-05	0.000324	CcSEcCtD
L-Glutamine—Hyperhidrosis—Epirubicin—breast cancer	4.3e-05	0.000322	CcSEcCtD
L-Glutamine—Insomnia—Methotrexate—breast cancer	4.3e-05	0.000322	CcSEcCtD
L-Glutamine—Myalgia—Doxorubicin—breast cancer	4.3e-05	0.000321	CcSEcCtD
L-Glutamine—Chest pain—Doxorubicin—breast cancer	4.3e-05	0.000321	CcSEcCtD
L-Glutamine—Arthralgia—Doxorubicin—breast cancer	4.3e-05	0.000321	CcSEcCtD
L-Glutamine—Discomfort—Doxorubicin—breast cancer	4.25e-05	0.000317	CcSEcCtD
L-Glutamine—Dizziness—Capecitabine—breast cancer	4.23e-05	0.000316	CcSEcCtD
L-Glutamine—Dry mouth—Doxorubicin—breast cancer	4.2e-05	0.000314	CcSEcCtD
L-Glutamine—Vomiting—Docetaxel—breast cancer	4.2e-05	0.000314	CcSEcCtD
L-Glutamine—Rash—Docetaxel—breast cancer	4.16e-05	0.000311	CcSEcCtD
L-Glutamine—Dermatitis—Docetaxel—breast cancer	4.16e-05	0.000311	CcSEcCtD
L-Glutamine—Headache—Docetaxel—breast cancer	4.13e-05	0.000309	CcSEcCtD
L-Glutamine—Oedema—Doxorubicin—breast cancer	4.12e-05	0.000308	CcSEcCtD
L-Glutamine—Fatigue—Methotrexate—breast cancer	4.1e-05	0.000307	CcSEcCtD
L-Glutamine—Infection—Doxorubicin—breast cancer	4.09e-05	0.000306	CcSEcCtD
L-Glutamine—Pain—Methotrexate—breast cancer	4.07e-05	0.000304	CcSEcCtD
L-Glutamine—Vomiting—Capecitabine—breast cancer	4.06e-05	0.000304	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Epirubicin—breast cancer	4.06e-05	0.000303	CcSEcCtD
L-Glutamine—Rash—Capecitabine—breast cancer	4.03e-05	0.000301	CcSEcCtD
L-Glutamine—Insomnia—Epirubicin—breast cancer	4.03e-05	0.000301	CcSEcCtD
L-Glutamine—Dermatitis—Capecitabine—breast cancer	4.03e-05	0.000301	CcSEcCtD
L-Glutamine—Headache—Capecitabine—breast cancer	4e-05	0.000299	CcSEcCtD
L-Glutamine—Hyperhidrosis—Doxorubicin—breast cancer	3.98e-05	0.000298	CcSEcCtD
L-Glutamine—Nausea—Docetaxel—breast cancer	3.92e-05	0.000293	CcSEcCtD
L-Glutamine—Feeling abnormal—Methotrexate—breast cancer	3.92e-05	0.000293	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Methotrexate—breast cancer	3.89e-05	0.000291	CcSEcCtD
L-Glutamine—Fatigue—Epirubicin—breast cancer	3.84e-05	0.000287	CcSEcCtD
L-Glutamine—Pain—Epirubicin—breast cancer	3.81e-05	0.000285	CcSEcCtD
L-Glutamine—Constipation—Epirubicin—breast cancer	3.81e-05	0.000285	CcSEcCtD
L-Glutamine—Nausea—Capecitabine—breast cancer	3.8e-05	0.000284	CcSEcCtD
L-Glutamine—Abdominal pain—Methotrexate—breast cancer	3.76e-05	0.000281	CcSEcCtD
L-Glutamine—Body temperature increased—Methotrexate—breast cancer	3.76e-05	0.000281	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.75e-05	0.000281	CcSEcCtD
L-Glutamine—Insomnia—Doxorubicin—breast cancer	3.73e-05	0.000279	CcSEcCtD
L-Glutamine—Feeling abnormal—Epirubicin—breast cancer	3.67e-05	0.000274	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Epirubicin—breast cancer	3.64e-05	0.000272	CcSEcCtD
L-Glutamine—Fatigue—Doxorubicin—breast cancer	3.55e-05	0.000266	CcSEcCtD
L-Glutamine—Pain—Doxorubicin—breast cancer	3.52e-05	0.000263	CcSEcCtD
L-Glutamine—Constipation—Doxorubicin—breast cancer	3.52e-05	0.000263	CcSEcCtD
L-Glutamine—Abdominal pain—Epirubicin—breast cancer	3.52e-05	0.000263	CcSEcCtD
L-Glutamine—Body temperature increased—Epirubicin—breast cancer	3.52e-05	0.000263	CcSEcCtD
L-Glutamine—Hypersensitivity—Methotrexate—breast cancer	3.5e-05	0.000262	CcSEcCtD
L-Glutamine—Asthenia—Methotrexate—breast cancer	3.41e-05	0.000255	CcSEcCtD
L-Glutamine—Feeling abnormal—Doxorubicin—breast cancer	3.39e-05	0.000254	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Doxorubicin—breast cancer	3.37e-05	0.000252	CcSEcCtD
L-Glutamine—Pruritus—Methotrexate—breast cancer	3.37e-05	0.000252	CcSEcCtD
L-Glutamine—Hypersensitivity—Epirubicin—breast cancer	3.28e-05	0.000245	CcSEcCtD
L-Glutamine—Abdominal pain—Doxorubicin—breast cancer	3.26e-05	0.000244	CcSEcCtD
L-Glutamine—Body temperature increased—Doxorubicin—breast cancer	3.26e-05	0.000244	CcSEcCtD
L-Glutamine—Asthenia—Epirubicin—breast cancer	3.19e-05	0.000239	CcSEcCtD
L-Glutamine—Pruritus—Epirubicin—breast cancer	3.15e-05	0.000236	CcSEcCtD
L-Glutamine—Dizziness—Methotrexate—breast cancer	3.15e-05	0.000235	CcSEcCtD
L-Glutamine—Hypersensitivity—Doxorubicin—breast cancer	3.03e-05	0.000227	CcSEcCtD
L-Glutamine—Vomiting—Methotrexate—breast cancer	3.02e-05	0.000226	CcSEcCtD
L-Glutamine—Rash—Methotrexate—breast cancer	3e-05	0.000224	CcSEcCtD
L-Glutamine—Dermatitis—Methotrexate—breast cancer	3e-05	0.000224	CcSEcCtD
L-Glutamine—Headache—Methotrexate—breast cancer	2.98e-05	0.000223	CcSEcCtD
L-Glutamine—Asthenia—Doxorubicin—breast cancer	2.96e-05	0.000221	CcSEcCtD
L-Glutamine—Dizziness—Epirubicin—breast cancer	2.94e-05	0.00022	CcSEcCtD
L-Glutamine—Pruritus—Doxorubicin—breast cancer	2.91e-05	0.000218	CcSEcCtD
L-Glutamine—Vomiting—Epirubicin—breast cancer	2.83e-05	0.000212	CcSEcCtD
L-Glutamine—Nausea—Methotrexate—breast cancer	2.83e-05	0.000211	CcSEcCtD
L-Glutamine—Rash—Epirubicin—breast cancer	2.81e-05	0.00021	CcSEcCtD
L-Glutamine—Dermatitis—Epirubicin—breast cancer	2.8e-05	0.00021	CcSEcCtD
L-Glutamine—Headache—Epirubicin—breast cancer	2.79e-05	0.000209	CcSEcCtD
L-Glutamine—Dizziness—Doxorubicin—breast cancer	2.72e-05	0.000204	CcSEcCtD
L-Glutamine—Nausea—Epirubicin—breast cancer	2.64e-05	0.000198	CcSEcCtD
L-Glutamine—Vomiting—Doxorubicin—breast cancer	2.62e-05	0.000196	CcSEcCtD
L-Glutamine—Rash—Doxorubicin—breast cancer	2.6e-05	0.000194	CcSEcCtD
L-Glutamine—Dermatitis—Doxorubicin—breast cancer	2.59e-05	0.000194	CcSEcCtD
L-Glutamine—Headache—Doxorubicin—breast cancer	2.58e-05	0.000193	CcSEcCtD
L-Glutamine—Nausea—Doxorubicin—breast cancer	2.45e-05	0.000183	CcSEcCtD
L-Glutamine—GMPS—Metabolism—PIK3CD—breast cancer	1.13e-05	8e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CD—breast cancer	1.13e-05	8e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—TYMS—breast cancer	1.13e-05	7.99e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CAV1—breast cancer	1.13e-05	7.99e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CAV1—breast cancer	1.13e-05	7.99e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CAV1—breast cancer	1.13e-05	7.99e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NCOA2—breast cancer	1.13e-05	7.97e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NCOA2—breast cancer	1.13e-05	7.97e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—AKT2—breast cancer	1.13e-05	7.95e-05	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—PIK3CA—breast cancer	1.13e-05	7.95e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ALB—breast cancer	1.12e-05	7.9e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PLA2G4A—breast cancer	1.12e-05	7.9e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—ALB—breast cancer	1.12e-05	7.9e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—COMT—breast cancer	1.12e-05	7.9e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—NCOR1—breast cancer	1.12e-05	7.9e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GSTM1—breast cancer	1.12e-05	7.9e-05	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—NCOA1—breast cancer	1.12e-05	7.89e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTP1—breast cancer	1.11e-05	7.86e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MDM2—breast cancer	1.11e-05	7.83e-05	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CB—breast cancer	1.11e-05	7.83e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—RAF1—breast cancer	1.11e-05	7.8e-05	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTGS2—breast cancer	1.1e-05	7.76e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—HMOX1—breast cancer	1.1e-05	7.76e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ITPR1—breast cancer	1.1e-05	7.74e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—FASN—breast cancer	1.1e-05	7.73e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—FASN—breast cancer	1.1e-05	7.73e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—ERBB2—breast cancer	1.09e-05	7.72e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—BCHE—breast cancer	1.09e-05	7.7e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—BCHE—breast cancer	1.09e-05	7.7e-05	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—breast cancer	1.09e-05	7.69e-05	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—PLG—breast cancer	1.09e-05	7.68e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—RAF1—breast cancer	1.09e-05	7.67e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CD—breast cancer	1.08e-05	7.64e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MTOR—breast cancer	1.08e-05	7.62e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3CB—breast cancer	1.08e-05	7.62e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—SLC5A5—breast cancer	1.08e-05	7.61e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—SLC5A5—breast cancer	1.08e-05	7.61e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CD4—breast cancer	1.08e-05	7.61e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GPX1—breast cancer	1.07e-05	7.57e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—NOS3—breast cancer	1.07e-05	7.56e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—NOS3—breast cancer	1.07e-05	7.56e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—SERPINE1—breast cancer	1.07e-05	7.56e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTGS2—breast cancer	1.07e-05	7.55e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CYP1A1—breast cancer	1.06e-05	7.49e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CB—breast cancer	1.06e-05	7.49e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ABCB1—breast cancer	1.05e-05	7.44e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ERCC2—breast cancer	1.05e-05	7.43e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—IGF1—breast cancer	1.05e-05	7.43e-05	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—HRAS—breast cancer	1.04e-05	7.36e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NQO1—breast cancer	1.04e-05	7.35e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NQO1—breast cancer	1.04e-05	7.35e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—SLC2A1—breast cancer	1.04e-05	7.35e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—SLC2A1—breast cancer	1.04e-05	7.35e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—ALB—breast cancer	1.04e-05	7.34e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CD—breast cancer	1.04e-05	7.32e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—TYMS—breast cancer	1.04e-05	7.31e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CG—breast cancer	1.03e-05	7.28e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CG—breast cancer	1.03e-05	7.28e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CG—breast cancer	1.03e-05	7.28e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—ALB—breast cancer	1.02e-05	7.23e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—NCOR1—breast cancer	1.02e-05	7.23e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GSTM1—breast cancer	1.02e-05	7.23e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PLA2G4A—breast cancer	1.02e-05	7.23e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NOS3—breast cancer	1.02e-05	7.22e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—MMP2—breast cancer	1.02e-05	7.19e-05	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—HRAS—breast cancer	1.02e-05	7.17e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP3A4—breast cancer	1.01e-05	7.16e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP3A4—breast cancer	1.01e-05	7.16e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CDKN1B—breast cancer	1.01e-05	7.15e-05	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—HMOX1—breast cancer	1e-05	7.09e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP1B1—breast cancer	9.98e-06	7.04e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP1B1—breast cancer	9.98e-06	7.04e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—MTHFR—breast cancer	9.89e-06	6.98e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CB—breast cancer	9.88e-06	6.98e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CB—breast cancer	9.88e-06	6.98e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GPX1—breast cancer	9.8e-06	6.92e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—NOS3—breast cancer	9.79e-06	6.91e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTGS2—breast cancer	9.79e-06	6.91e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTGS2—breast cancer	9.79e-06	6.91e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—HSP90AA1—breast cancer	9.78e-06	6.91e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—HSP90AA1—breast cancer	9.78e-06	6.91e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IL2—breast cancer	9.74e-06	6.88e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CYP1A1—breast cancer	9.7e-06	6.85e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MDM2—breast cancer	9.7e-06	6.85e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—RAF1—breast cancer	9.66e-06	6.82e-05	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ABCB1—breast cancer	9.64e-06	6.81e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ERCC2—breast cancer	9.62e-06	6.79e-05	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTEN—breast cancer	9.58e-06	6.76e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CTNNB1—breast cancer	9.57e-06	6.76e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—ERBB2—breast cancer	9.56e-06	6.75e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NCOA1—breast cancer	9.52e-06	6.72e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NCOA1—breast cancer	9.52e-06	6.72e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CB—breast cancer	9.43e-06	6.66e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MTOR—breast cancer	9.43e-06	6.66e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CD4—breast cancer	9.42e-06	6.65e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—RAF1—breast cancer	9.41e-06	6.64e-05	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MAPK3—breast cancer	9.38e-06	6.62e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—STK11—breast cancer	9.38e-06	6.62e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—STK11—breast cancer	9.38e-06	6.62e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP19A1—breast cancer	9.38e-06	6.62e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP19A1—breast cancer	9.38e-06	6.62e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CDKN1A—breast cancer	9.35e-06	6.6e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTGS2—breast cancer	9.35e-06	6.6e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTEN—breast cancer	9.33e-06	6.58e-05	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—AKT1—breast cancer	9.2e-06	6.49e-05	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MYC—breast cancer	9.13e-06	6.44e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CAV1—breast cancer	9.12e-06	6.44e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CD—breast cancer	9.06e-06	6.4e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CD—breast cancer	9.06e-06	6.4e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CD—breast cancer	9.06e-06	6.4e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—MTHFR—breast cancer	9.05e-06	6.39e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CB—breast cancer	9.04e-06	6.38e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTGS2—breast cancer	8.96e-06	6.32e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ALB—breast cancer	8.95e-06	6.32e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ALB—breast cancer	8.95e-06	6.32e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ALB—breast cancer	8.95e-06	6.32e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CDKN1B—breast cancer	8.85e-06	6.25e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—COMT—breast cancer	8.72e-06	6.16e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—COMT—breast cancer	8.72e-06	6.16e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTP1—breast cancer	8.68e-06	6.13e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTP1—breast cancer	8.68e-06	6.13e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—SRC—breast cancer	8.65e-06	6.11e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—NOS3—breast cancer	8.56e-06	6.04e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—NOS3—breast cancer	8.56e-06	6.04e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—NOS3—breast cancer	8.56e-06	6.04e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—HMOX1—breast cancer	8.56e-06	6.04e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—HMOX1—breast cancer	8.56e-06	6.04e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTEN—breast cancer	8.54e-06	6.03e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ITPR1—breast cancer	8.54e-06	6.03e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ITPR1—breast cancer	8.54e-06	6.03e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTEN—breast cancer	8.54e-06	6.03e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—SRC—breast cancer	8.5e-06	6e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CXCL8—breast cancer	8.46e-06	5.97e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CTNNB1—breast cancer	8.36e-06	5.9e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CAV1—breast cancer	8.34e-06	5.89e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—STAT3—breast cancer	8.34e-06	5.89e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CG—breast cancer	8.31e-06	5.87e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—VEGFA—breast cancer	8.28e-06	5.85e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ABCB1—breast cancer	8.21e-06	5.8e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ABCB1—breast cancer	8.21e-06	5.8e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CDKN1A—breast cancer	8.17e-06	5.77e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTEN—breast cancer	8.15e-06	5.76e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—TYMS—breast cancer	8.07e-06	5.7e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—TYMS—breast cancer	8.07e-06	5.7e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PLA2G4A—breast cancer	7.97e-06	5.63e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GSTM1—breast cancer	7.97e-06	5.63e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PLA2G4A—breast cancer	7.97e-06	5.63e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GSTM1—breast cancer	7.97e-06	5.63e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NCOR1—breast cancer	7.97e-06	5.63e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NCOR1—breast cancer	7.97e-06	5.63e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MAPK3—breast cancer	7.97e-06	5.63e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CB—breast cancer	7.9e-06	5.58e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CB—breast cancer	7.9e-06	5.58e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CB—breast cancer	7.9e-06	5.58e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—MAPK3—breast cancer	7.83e-06	5.53e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTGS2—breast cancer	7.83e-06	5.53e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTGS2—breast cancer	7.83e-06	5.53e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTGS2—breast cancer	7.83e-06	5.53e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTEN—breast cancer	7.81e-06	5.51e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CTNNB1—breast cancer	7.81e-06	5.51e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MYC—breast cancer	7.75e-06	5.47e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—TGFB1—breast cancer	7.73e-06	5.46e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GPX1—breast cancer	7.64e-06	5.39e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GPX1—breast cancer	7.64e-06	5.39e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CG—breast cancer	7.6e-06	5.37e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TGFB1—breast cancer	7.6e-06	5.37e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EGFR—breast cancer	7.58e-06	5.35e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP1A1—breast cancer	7.56e-06	5.34e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP1A1—breast cancer	7.56e-06	5.34e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—SRC—breast cancer	7.56e-06	5.34e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ERCC2—breast cancer	7.5e-06	5.29e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ERCC2—breast cancer	7.5e-06	5.29e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CD—breast cancer	7.31e-06	5.16e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—STAT3—breast cancer	7.29e-06	5.15e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ALB—breast cancer	7.21e-06	5.09e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—KRAS—breast cancer	7.16e-06	5.06e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—MTHFR—breast cancer	7.05e-06	4.98e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—MTHFR—breast cancer	7.05e-06	4.98e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—KRAS—breast cancer	7.04e-06	4.97e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MAPK3—breast cancer	6.96e-06	4.92e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—NOS3—breast cancer	6.9e-06	4.87e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTEN—breast cancer	6.83e-06	4.82e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTEN—breast cancer	6.83e-06	4.82e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTEN—breast cancer	6.83e-06	4.82e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MYC—breast cancer	6.77e-06	4.78e-05	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CA—breast cancer	6.76e-06	4.77e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—TGFB1—breast cancer	6.76e-06	4.77e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CD—breast cancer	6.68e-06	4.72e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EGFR—breast cancer	6.63e-06	4.68e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ALB—breast cancer	6.6e-06	4.66e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PIK3CA—breast cancer	6.58e-06	4.64e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CAV1—breast cancer	6.5e-06	4.59e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CAV1—breast cancer	6.5e-06	4.59e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CA—breast cancer	6.47e-06	4.57e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CB—breast cancer	6.37e-06	4.5e-05	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—AKT1—breast cancer	6.33e-06	4.47e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—NOS3—breast cancer	6.31e-06	4.45e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTGS2—breast cancer	6.31e-06	4.45e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KRAS—breast cancer	6.26e-06	4.42e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—breast cancer	6.26e-06	4.42e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HRAS—breast cancer	6.09e-06	4.3e-05	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ALB—breast cancer	6.03e-06	4.26e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CA—breast cancer	6.02e-06	4.25e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CA—breast cancer	6.02e-06	4.25e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—HRAS—breast cancer	5.98e-06	4.22e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CG—breast cancer	5.92e-06	4.18e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CG—breast cancer	5.92e-06	4.18e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—IL6—breast cancer	5.83e-06	4.11e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CB—breast cancer	5.82e-06	4.11e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTGS2—breast cancer	5.77e-06	4.07e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PIK3CA—breast cancer	5.75e-06	4.06e-05	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—AKT1—breast cancer	5.52e-06	3.9e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CA—breast cancer	5.51e-06	3.89e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTEN—breast cancer	5.5e-06	3.88e-05	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—RAF1—breast cancer	5.45e-06	3.85e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—AKT1—breast cancer	5.37e-06	3.79e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HRAS—breast cancer	5.32e-06	3.76e-05	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—AKT1—breast cancer	5.28e-06	3.73e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CD—breast cancer	5.21e-06	3.68e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CD—breast cancer	5.21e-06	3.68e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ALB—breast cancer	5.14e-06	3.63e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ALB—breast cancer	5.14e-06	3.63e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—IL6—breast cancer	5.09e-06	3.6e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTEN—breast cancer	5.03e-06	3.55e-05	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—AKT1—breast cancer	4.92e-06	3.47e-05	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—AKT1—breast cancer	4.92e-06	3.47e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NOS3—breast cancer	4.92e-06	3.47e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NOS3—breast cancer	4.92e-06	3.47e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CA—breast cancer	4.82e-06	3.4e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CA—breast cancer	4.82e-06	3.4e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CA—breast cancer	4.82e-06	3.4e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—AKT1—breast cancer	4.7e-06	3.32e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CB—breast cancer	4.54e-06	3.2e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CB—breast cancer	4.54e-06	3.2e-05	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—AKT1—breast cancer	4.5e-06	3.18e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTGS2—breast cancer	4.5e-06	3.17e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTGS2—breast cancer	4.5e-06	3.17e-05	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—AKT1—breast cancer	3.93e-06	2.78e-05	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—AKT1—breast cancer	3.93e-06	2.78e-05	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—AKT1—breast cancer	3.93e-06	2.78e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTEN—breast cancer	3.92e-06	2.77e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTEN—breast cancer	3.92e-06	2.77e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CA—breast cancer	3.88e-06	2.74e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CA—breast cancer	3.55e-06	2.51e-05	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—AKT1—breast cancer	3.17e-06	2.24e-05	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—AKT1—breast cancer	2.9e-06	2.05e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CA—breast cancer	2.77e-06	1.95e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CA—breast cancer	2.77e-06	1.95e-05	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—AKT1—breast cancer	2.26e-06	1.6e-05	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—AKT1—breast cancer	2.26e-06	1.6e-05	CbGpPWpGaD
